GeekWire

JULY 15, 2021

Sana Biotechnology , a young and fast-growing Seattle-based biotech, has chosen the San Francisco Bay Area as the site for its new biomanufacturing facility. Competition for researchers skilled in biomanufacturing and other areas can be stiff, and the Bay Area is a much larger, more established biotechnology hub than Seattle.

Biotechnology 114

Biotechnology Development Construction Advertising 114

GeekWire

JANUARY 13, 2021

Less than three years after it was founded and with no revenue on the books, Sana Biotechnology has f iled to go public. And like many biotechnology companies it is losing money. Sana would become the latest in a string of Seattle area biotechnology companies to join the public ranks in recent months. stake in Sana.

Biotechnology 145

Biotechnology Applications .Net Government 145

GeekWire

FEBRUARY 3, 2021

Sana Biotechnology — the Seattle upstart that’s looking to treat a variety of diseases through gene therapy and cell engineering — is generating buzz on Wall Street. That would net the biotechnology company $517 million if it sold at the midpoint of that range. Sana’s technology (screen grab via IPO filing).

Biotechnology 105

Biotechnology .Net Engineering Applications 105

GeekWire

FEBRUARY 15, 2022

Adaptive Biotechnologies , which develops technology to assess the immune response, posted $154.3 Adaptive moved into its new headquarters in September. Co-founders Harlan (left) and Chad Robins on the new plaza. GeekWire Photo / Charlotte Schubert). million in revenue last year, a 57% year-over-year increase.

Biotechnology 98

Biotechnology .Net Development Report 98

GeekWire

MARCH 9, 2022

Adaptive Biotechnologies has a new CFO. Tycho Peterson, Adaptive’s new CFO. Morgan Chase Photo). Tycho Peterson comes from J.P. Morgan Chase, where he most recently served in its healthcare group as managing director, life science tools and diagnostics.

Biotechnology 98

Biotechnology Healthcare Open Source Sports 98

GeekWire

FEBRUARY 1, 2021

Adaptive Biotechnologies). Adaptive Biotechnologies has promoted one exec, while another is departing next month. Adaptive Biotechnologies’ EVP of Operations and Management Nancy Hill will depart the company in March. Bevier joined the F5 board in 2006. Mark Adams. Mark Adams is now COO.

Biotechnology 117

Biotechnology Fractional CTO CTO Hire Telecommunications 117

GeekWire

OCTOBER 19, 2021

Sana Biotechnology has a new $50 million tool in its toolbox. Sana CEO and president Steve Harr. Sana Photo). Sana signed an agreement with Beam Therapeutics for non-exclusive commercial rights to the Cambridge, Mass.-based based biotech’s gene editing system, called CRISPR-Cas12b.

Biotechnology 135

Biotechnology System Programming Engineering 135

GeekWire

NOVEMBER 10, 2020

Adaptive Biotechnologies CEO Chad Robins. Adaptive Biotechnologies beat expectations for its fiscal third quarter as the Seattle company continues to use its immune medicine platform in the fight against COVID-19. GeekWire Photo). Adaptive posted revenue of $26.3 million, up 1% year-over-year, and earnings per share of -$0.27.

Biotechnology 82

Biotechnology Pharmaceuticals Microsoft System 82

GeekWire

FEBRUARY 8, 2021

Nautilus Biotechnology co-founders Sujal Patel (left) and Parag Mallick. Nautilus Biotechnology , a Seattle-based biotech startup led by Isilon co-founder Sujal Patel , is the latest company to go public using a special purpose acquisition company, or SPAC. Nautilus Photo).

Biotechnology 145

Biotechnology .Net Wireless Hardware 145

GeekWire

JULY 14, 2020

Adaptive Biotechnologies announced Tuesday that it will sell 8 million shares of its common stock — 6 million of its own, and 2 million from an investor — to help accelerate the company’s work.

Biotechnology 75

Biotechnology Development Microsoft System 75

GeekWire

JUNE 9, 2021

Nautilus Biotechnology co-founders Sujal Patel (left) and Parag Mallick. Nautilus Biotechnology is emerging as Seattle’s newest publicly traded company this week, taking advantage of the mania over SPACs to raise $345 million to fuel a new approach that could accelerate biomedical research and transform drug development.

Biotechnology 131

Biotechnology Analysis Engineering Research 131

GeekWire

SEPTEMBER 21, 2021

Adaptive co-founders Harlan (left) and Chad Robins on the plaza at the new Adaptive Biotechnology headquarters. After doubling its workforce during the pandemic, Adaptive Biotechnologies finally has room to grow. GeekWire Photos / Charlotte Schubert).

Biotechnology 98

Biotechnology Real Estate Analysis Windows 98

GeekWire

NOVEMBER 9, 2023

Adaptive Biotechnologies CEO Chad Robins speaks at the GeekWire Summit in 2019.

Biotechnology 107

Biotechnology Real Estate .Net Conference 107

GeekWire

JULY 27, 2020

Chad Robins, CEO of Adaptive Biotechnologies, speaks at the site of the company’s future corporate headquarters in Seattle, standing in front of the final piece of structural steel before it’s put into place. Stephen Brashear/AP Images for Adaptive Biotechnologies). Stephen Brashear/AP Images for Adaptive Biotechnologies).

Biotechnology 134

Biotechnology Real Estate Industry Microsoft 134

GeekWire

APRIL 15, 2021

Chad Robins, left, is co-founder and CEO of Adaptive Biotechnologies, which he co-founded with his brother, Harlan Robins, right, a theoretical physicist turned computational biologist who is the company’s chief scientific officer. Adaptive Biotechnologies Photo).

Biotechnology 111

Biotechnology Web Services Education Software Development 111

GeekWire

APRIL 12, 2023

Workplace of the Year finalists, clockwise from top left: Adaptive Biotechnologies co-founders Harlan and Chad Robins; the Helion team; Impinj offices in Seattle; Treasury4 team; Blink CEO Karen Clark Cole. This year’s finalists are Adaptive Biotechnologies, Blink, Helion, Impinj and Treasury4. Blink Blink CEO Karen Clark Cole.

Biotechnology 98

Biotechnology Policies Energy Meeting 98

Vox

NOVEMBER 29, 2023

In both his book and his newsletter, Azhar predicts coming advances in fields like artificial intelligence and biotechnology that will be capable of carrying us into a true age of abundance, one where we can have more energy but fewer carbon emissions, more food but less pollution, where we can live longer and healthier.

Biotechnology 59

Biotechnology Artificial Intelligence Energy Engineering 59

GeekWire

AUGUST 23, 2021

In the previous four years, Adaptive Biotechnologies was the only Washington state biotech company to go public. Sana Biotechnology, for instance, is led by Steve Harr , former CFO and corporate development head at Juno Therapeutics, a Seattle company that went public in 2014 and was later acquired by Celgene for $9 billion.

Biotechnology 130

Biotechnology Company Software Software 130

GeekWire

JULY 18, 2023

After announcing in March that it was seeking “strategic alternatives” for its future, Seattle publicly-traded biotechnology company Neoleukin Therapeutics is now planning to merge with New York City-based Neurogene, a gene therapy startup.

Biotechnology 98

Biotechnology Company Development 98

GeekWire

JULY 8, 2021

Absci is the latest in a string of Washington state biotech startups to test the public markets — others including Impel Neuropharma, Sana Biotechnology, Athira Pharma, and Silverback Therapeutics have had IPOs in the past year. The amount of investment that is pouring into biotechnology and the life sciences is incredible,” said Alexandre.

Biotechnology 133

Biotechnology Industry Real Estate Company 133

GeekWire

OCTOBER 15, 2023

… Read More Sana Biotechnology will lay off 29% of workforce Sana Biotechnology will reduce its workforce by 29%, the Seattle-based cell and gene therapy company revealed in a SEC filing Tuesday. … Read More Coast Guard brings up additional debris and remains from OceanGate sub wreck The U.S.

Biotechnology 106

Biotechnology Microsoft Real Estate Research 106

GeekWire

JANUARY 14, 2022

The Bill & Melinda Gates Foundation has committed $40 million in equity investment and $10 million in grant funding to Vir Biotechnology for the development of therapies against HIV and Malaria, Vir announced Friday. government has been buying to fight Omicron.

Biotechnology 107

Biotechnology Government Research Development 107

GeekWire

JULY 29, 2021

The amount of investment that is pouring into biotechnology and the life sciences is incredible,” said Leslie Alexandre, CEO of Life Sciences Washington. Biotech IPOs reached an all-time high last year, according to Biopharma Dive , and the pace is continuing into 2021.

Biotechnology 140

Biotechnology Company Pharmaceuticals Research 140

GeekWire

JUNE 30, 2021

The company, founded in 2011, began commercial operations in 2018 and now has partnerships with Merck, Xyphos Biotechnology, Alpha Cancer Technologies and several other drug companies. Three Washington state companies — Sana Biotechnology , Impel Neuropharma and Paymentus — have gone public with a traditional IPO this year.

Biotechnology 133

Biotechnology Company .Net Programming 133

GeekWire

NOVEMBER 7, 2022

Laura Cooper , previously senior director of corporate communications at Adaptive Biotechnologies, joined Day One Biopharmaceuticals as head of corporate communications. Pittenger remained at Cint as CTO for about a year before joining DexCare in November.

CTO 111

CTO CTO Hire Biotechnology Nonprofit 111

GeekWire

AUGUST 10, 2020

Chad Robins, left, is co-founder and CEO of Adaptive Biotechnologies, which he co-founded with his brother, Harlan Robins, right, a theoretical physicist turned computational biologist who is the company’s chief scientific officer. Adaptive Biotechnologies Photo).

Biotechnology 120

Biotechnology Industry Microsoft .Net 120

GeekWire

APRIL 18, 2023

The category highlights pioneering health, life science, biotechnology or medical breakthroughs that hold great promise for bettering our lives or improving the healthcare system. A fifth company is the brainchild of a founder previously at Pacific Northwest Research Institute (PNRI).

Biotechnology 126

Biotechnology Healthcare Artificial Intelligence Software 126

SecureWorld News

JULY 19, 2023

These scams employ deceptive tactics, preying on students' aspirations for job opportunities in the healthcare, biosciences, and biotechnology sectors, among others. The threat actors used email lures with job-themed subject lines, appearing to come from reputable organizations related to biosciences, healthcare, and biotechnology.

Biotechnology 80

Biotechnology Healthcare Analysis Video 80

GeekWire

DECEMBER 30, 2020

In June, Seattle biotechnology upstart Sana Biotechnology revealed that it had raised more than $700 million in venture funding. Which of these Washington state companies did NOT go public in 2020: Accolade, Adaptive Biotechnologies, Athira Pharma, Silverback Therapeutics? Adaptive Biotechnologies (It went public in 2019).

Biotechnology 135

Biotechnology Sports Microsoft Cloud 135

GeekWire

AUGUST 11, 2021

So how do Washington state’s technology and biotechnology companies measure up? However, Adaptive Biotechnologies went public only two years ago, and it appears the rule does not apply for the first four to five years after an IPO. RELATED: The push for corporate board diversity is growing. Seemingly better.

Biotechnology 103

Biotechnology Company Microsoft Meeting 103

Gizmodo

JULY 14, 2021

An expert committee says heritable genome editing of humans is still too risky and that the World Health Organization should take on a leading role when it comes to regulating this emerging biotechnology. Read more.

Biotechnology 79

Biotechnology Engineering 79

GeekWire

NOVEMBER 13, 2020

Adaptive Biotechnologies says it’s proceeding with plans to launch a new type of test to determine if someone was previously infected with SARS-CoV-2, the virus that causes COVID-19, after a study added to the evidence that its approach is more accurate than currently available antibody tests. Adaptive Biotechnologies Photo).

Biotechnology 138

Biotechnology Comparison Microsoft .Net 138

GeekWire

JUNE 14, 2023

Adaptive Biotechnologies Corporation disclosed in a SEC filing that Leslie Trigg is voluntarily resigning from the company’s board. Cyemptive, founded in 2014, sells cybersecurity tools including an endpoint protection service and advanced perimeter firewalls. It acquired Adaptive Technology Group in 2019.

CTO Hire 114

CTO Hire Fractional CTO Fractional VPE CTO 114

GeekWire

FEBRUARY 15, 2022

Madrona has historically backed tech companies but is increasingly investing in companies at the convergence of life and computer sciences, such as A-Alpha Bio, Ozette and Nautilus Biotechnology.

Artificial Intelligence 98

Artificial Intelligence Biotechnology Company Groups 98

GeekWire

JANUARY 5, 2021

Nautilus Biotechnology Photos). Sujal Patel is getting the band back together at his secretive new biotech startup Nautilus Biotechnology. Nautilus Biotechnology co-founders Sujal Patel and Parag Mallick. Now they are quickly building out their team, helped by a $76 million Series B round raised last year. Nautilus Photo).

Biotechnology 136

Biotechnology Web Services Hardware Microsoft 136

GeekWire

APRIL 16, 2021

The category highlights pioneering health, life science, biotechnology or medical breakthroughs that hold great promise for bettering our lives or improving the healthcare system. Adaptive Biotechnologies. So it’s little wonder that there’s stiff competition for the 2021 GeekWire Health Innovation of the Year.

Biotechnology 122

Biotechnology Artificial Intelligence Virtualization Healthcare 122

GeekWire

JULY 2, 2020

OncoSenX is the spinoff of a third company, Seattle-based Oisin Biotechnologies. The researchers said they have selected the two most promising DNA sequences for further testing. Researchers at OncoSenX are using Fusogenix for cancer research on the treatment of solid tumors.

Research 145

Research Biotechnology Pharmaceuticals Development 145